Intimation of participation in the Investors Meeting
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mankind Pharma has disclosed that its management and officials will meet with investors in person in Singapore on May 25-26, 2026. The meeting is a routine investor outreach activity. The company has explicitly stated that no unpublished price sensitive information (UPSI) will be shared during the meeting, and discussions will be limited to general business outlook and publicly available information. The schedule may change due to exigencies.
This is a standard investor relations disclosure with no immediate impact on the stock. It signals proactive compliance with SEBI disclosure norms and suggests active investor engagement.